April 2019. An experimental compound inhibited clot formation without increased bleeding, a common side effect of current anticlotting therapies, in a phase I study.
Couverture média
18 avril 2019
April 2019. An experimental compound inhibited clot formation without increased bleeding, a common side effect of current anticlotting therapies, in a phase I study.